Stephen Mateka, DO
Dr Mateka is the medical director of psychiatry for Inspira Health and serves as cochair of psychiatry. He is the president of the New Jersey Psychiatric Association (NJPA) and serves on the Inpatient/Partial Hospitalization/Residential Committee and Public Resources Committee for the American Academy of Child and Adolescent Psychiatry (AACAP). Mateka is also psychiatrist adviser for PerformCare, where he works closely with the New Jersey Department of Children and Families and Children’s System of Care.
Articles
Clinicians’ Experience with ADHD Treatments
Panelists discuss how viloxazine fits into both pediatric and adult ADHD treatment plans, especially as a non-stimulant option for patients with complex cases or concerns about stimulant side effects, while emphasizing flexible dosing and caregiver involvement.
Viloxazine for ADHD in Children and Adolescents
Panelists discuss how recent clinical studies on viloxazine in children and adolescents demonstrated early symptom improvement, dose-dependent efficacy, and tolerability, with the most benefit seen at 400 mg in those aged 11 and under.
Impact of ADHD on Patient’s Quality of Life
Panelists discuss how ADHD diagnosis impacts families through stress and challenges but can also provide relief and understanding, while addressing quality of life effects including academic performance, family functioning, driving safety, and the need for structure and routine management.
Panelists discuss how diagnostic challenges include ensuring symptoms are developmentally appropriate, distinguishing ADHD from other conditions like depression and anxiety, and using tools like Vanderbilt and Connors scales to assess symptoms across multiple settings.
Panelists discuss how the DSM-5-TR criteria for ADHD require at least 6 of 9 symptoms in either inattentive or hyperactive-impulsive domains, with inattentive presentations often going unrecognized especially in females and highly intelligent students.
ADHD in Elementary School Age Child: Patient Case 1
Panelists discuss how ADHD presents in a 10-year-old boy with combined presentation symptoms, emphasizing the importance of seeing difficulties across multiple settings and noting the genetic component when family history is present.
